Golimumab Subcutaneous and Recombinate recombinant
Determining the interaction of Golimumab Subcutaneous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Recombivax
- Golimumab Subcutaneous-Recombivax HB
- Golimumab Subcutaneous-Recombivax HB Adult
- Golimumab Subcutaneous-Recombivax HB Dialysis Formulation
- Golimumab Subcutaneous-Recombivax HB Pediatric/Adolescent
- Golimumab Subcutaneous-Recort Plus
- Recombinate recombinant-GoLYTELY
- Recombinate recombinant-Gonadorelin
- Recombinate recombinant-Gonadorelin Intravenous, Injection
- Recombinate recombinant-Gonadotropin, Chorionic
- Recombinate recombinant-Gonal-F
- Recombinate recombinant-Gonal-f RFF